Full Text (PDF)
Case Report

Decreased Platelet Count Due to Heparin in Covid-19

Ashar Khan1, , Ashar Khan1 , Kishalay Datta2 , Siddharth Verma3 , Arun Kaushik4

Author Information

Licence:




Indian Journal of Emergency Medicine 7(1):p 43-45, jan-march 2021. | DOI: http://dx.doi.org/10.21088/ijem.2395.311X.7121.8

How Cite This Article:

Ashar Khan, Kishalay Datta, Siddharth Verma, et al / Decreased Platelet Count Due to Heparin in Covid-19. Indian J Emerg Med.
2021;7(1):43–45.


Timeline

Received : N/A         Accepted : N/A          Published : N/A

Abstract

COVID-19 (coronavirus disease-2019) infection may be a extremely prothrombotic state, ensuing from a dysregulation of the coagulation cascade. Therefore, thromboprophylaxis is powerfully suggested in these patients, with some consultants even advocating for therapeutic dosing to forestall thromboembolic events. Heparin-induced blood disorder (HIT) may be a well-known complication of heparin therapy. during this article, we tend to report a case of HIT in a patient with COVID-19. A 52-year-old male with history of one week of dry cough and loose stools. He had a positive COVID-19 reverse-transcriptase–polymerase chain reaction. On admission, the platelet count and liver function test were within normal limits. Throughout his hospitalization, he developed a right femoral deep venous thrombosis and was started on therapeutic anticoagulations. Due to worsening respiratory failure, he was intubated and mechanically ventilated. Between days eight and nine of hospitalization, platelet count decreased from 294000 to 89000 cells/μL. He had a high pretest likelihood for HIT with a 4T score of 6 and a positive anti-PF4/ heparin antibody. Heparin drip was interrupted and was switched to Argatroban. The serotinin assay eventually came back positive, that confirmed the diagnosis of HIT.


References

No records found.


About this article


Cite this article

Ashar Khan, Kishalay Datta, Siddharth Verma, et al / Decreased Platelet Count Due to Heparin in Covid-19. Indian J Emerg Med.
2021;7(1):43–45.


Licence:




Received Accepted Published
N/A N/A N/A

DOI: http://dx.doi.org/10.21088/ijem.2395.311X.7121.8

Keywords


Article Level Metrics

Last Updated

Wednesday 17 June 2026, 16:06:21 (IST)


2147

Accesses

2
735
00

Citations


NA
NA
NA

Download citation


Article Keywords


Keyword Highlighting

Highlight selected keywords in the article text.


Timeline


Received N/A
Accepted N/A
Published N/A

licence



Access this article



Share